BUY NOVOSARM – YK-11 (10 MG/ML – 30 ML)
MAIN PRODUCT DESCRIPTION
Product Overview
NovoSARM – YK-11 (10 mg/ml – 30 ml) is the product identified in the supplied heading and product URL. However, the detailed material provided beneath the product heading does not describe YK-11. Instead, the entire supplied description discusses Cardarine (GW-501516), including its proposed development history, PPAR-related metabolic research, endurance claims and lipid-related research.
Because the information supplied does not contain verified YK-11 specifications or a YK-11-specific scientific description, it would be inaccurate to rewrite the Cardarine material as though it applied to YK-11. To maintain factual accuracy, unsupported YK-11 characteristics have not been invented.
Product Specifications
- Product: NovoSARM – YK-11
- Stated Strength: 10 mg/ml
- Stated Pack Size: 30 ml
- Active Compound: YK-11
- Presentation: 30 ml liquid product according to the supplied heading
- Manufacturer: Not provided in the supplied YK-11 information
- Molecular Formula: Not provided
- Molecular Weight: Not provided
- CAS Number: Not provided
- Dosage Form: Not independently specified
- Route: Not provided
- Market/Regulatory Status: Not provided
Important Source-Data Issue
The supplied content contains a clear product mismatch.
The heading identifies YK-11, but the accompanying text repeatedly identifies Cardarine and GW-501516. For example, the supplied material discusses the development of GW501516 in cancer-related research and describes proposed effects involving lipid metabolism, vascular pathways, endurance and fat utilisation.
Those statements cannot safely be transferred to YK-11 because YK-11 and GW-501516 are different research compounds with different chemical structures and pharmacological classifications.
This distinction is particularly important for pharmaceutical e-commerce content. Using Cardarine information on a YK-11 product page could result in incorrect claims about the active compound, mechanism of action, clinical research and safety.
Pharmacological Information
The supplied material does not provide a reliable YK-11-specific pharmacological description.
The text supplied refers to GW-501516 and describes research involving metabolic regulation and lipid-related pathways. Because that information belongs to another compound, it has not been presented here as YK-11 pharmacology.
No specific information concerning YK-11’s molecular targets, receptor activity, mechanism of action, pharmacokinetics, biological pathways or documented clinical applications was included in the source material provided for this listing.
Research Context
The supplied source mentions research into Cardarine involving metabolic and vascular pathways and describes experimental observations concerning endurance, fat metabolism and metabolic parameters.
However, these statements relate to GW-501516/Cardarine, not YK-11. They should therefore be removed from the YK-11 product page unless a reliable source confirms that they were intended for another product.
Similarly, the supplied text contains claims about fat burning, muscle gain, stamina, cardiovascular effects, liver effects and metabolic improvements. These cannot be attributed to YK-11 based on the information supplied.
YK-11 Product Information
For this particular YK-11 listing, the only product-specific information supplied is:
NovoSARM – YK-11
Strength: 10 mg/ml
Pack Size: 30 ml
The source does not provide sufficient information to safely establish:
- A molecular formula
- Molecular weight
- CAS number
- Pharmacological class
- Validated mechanism of action
- Pharmacokinetic profile
- Human clinical indications
- Clinical efficacy
- Contraindications
- Adverse reactions
- Drug interactions
- Storage conditions
- Manufacturer information
- Regulatory authorisation
These details should not be guessed or transferred from other SARMs or research compounds.
Regulatory Considerations
The supplied information does not provide an EU marketing authorisation, national marketing authorisation number or approved therapeutic indication for YK-11.
Accordingly, no claim has been made that the product is an EU-authorised medicine or an approved treatment for muscle growth, fat loss, athletic performance, osteoporosis, muscle wasting or any other medical condition.
The product should not be described as clinically proven or medically approved unless appropriate authoritative documentation is available.
Fitness and Performance Claims
The supplied Cardarine material contains numerous fitness-related claims concerning fat burning, endurance, muscle development and body composition. These claims should not be attached to the YK-11 listing.
Likewise, no claims have been made that YK-11 is suitable for bodybuilding, cutting, bulking, body recomposition or athletic performance because the source material provided does not substantiate those claims for YK-11.
Safety Information
No YK-11-specific safety profile was supplied.
It would therefore be inappropriate to state that YK-11 is safe, non-toxic, minimally suppressive, free from liver effects or free from other adverse reactions. The absence of safety information is not evidence of an absence of risk.
Any scientifically or commercially responsible product page should clearly distinguish known evidence from unsupported marketing statements.
Dosage and Administration
The supplied material does not provide a reliable YK-11-specific dosage or administration protocol.
No dosing schedule has therefore been invented or transferred from other SARMs. The stated 10 mg/ml refers to the product strength provided in the heading and should not be interpreted as a recommended human dose.
Storage
Specific YK-11 storage conditions were not supplied.
The product should therefore be stored according to the current manufacturer’s label and technical documentation. No temperature range has been invented.
Manufacturer Information
The supplied material identifies the product as NovoSARM – YK-11, but it does not provide sufficient manufacturer information specific to this listing.
No additional company, production, batch or regulatory details have been added.
Important Product Notice
The current source material for this listing requires correction before publication. The product heading says YK-11, while the supplied description is specifically about Cardarine (GW-501516).
For SEO, regulatory accuracy and customer protection, Cardarine-specific claims should not be published under the YK-11 product name.
Until YK-11-specific documentation is supplied, the safest product description is limited to the verified information: NovoSARM – YK-11, 10 mg/ml, 30 ml.
This description is based solely on the information supplied and does not establish clinical efficacy, safety, regulatory approval or a human treatment regimen.
